Infectious Disease Market To Surpass USD 24.5 Billion By 2030 At A CAGR Of 5.7%
The report analyzes and forecasts the Infectious Disease Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Infectious Disease Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Infectious Disease Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Infectious Disease Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2624
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The prominent players of the global infectious disease market involve Becton Dickinson and Company, bioMérieux SA, Abbott Laboratories, Quidel Corporation, OraSure Technologies, Danaher Corporation, and among others
The major market segments of Infectious Disease Market are as below:
Market By Product
Instruments
Reagents
Services
Market By Application
MRSA
Streptococcus
Clostridium Difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
COVID-19
Others
Market By Technology
Immunoassay
Molecular Diagnostics
Microbiology
Others
Market By End-User
Point of care
Central Laboratories
Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Infectious Disease
1.1. Definition and Scope
1.1.1. Definition of Infectious Disease
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Infectious Disease Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Infectious Disease Market By Product
1.2.3. Infectious Disease Market By Application
1.2.4. Infectious Disease Market By Technology
1.2.5. Infectious Disease Market By End-use
1.2.6. Infectious Disease Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Infectious Disease Market By Product
4.1. Introduction
4.2. Infectious Disease Revenue By Product
4.2.1. Infectious Disease Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Instruments
4.2.2.1. Instruments Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Reagents
4.2.3.1. Reagents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Services
4.2.4.1. Services Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Infectious Disease Market Revenue By Application
5.1. Introduction
5.2. Infectious Disease Revenue (US$ Mn) By Application
5.2.1. Infectious Disease Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
5.2.2. MRSA
5.2.2.1. MRSA Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Streptococcus
5.2.3.1. Streptococcus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Clostridium Difficile
5.2.4.1. Clostridium Difficile Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. VRE
5.2.5.1. VRE Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. CRE
5.2.6.1. CRE Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Respiratory Virus
5.2.7.1. Respiratory Virus Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Candida
5.2.8.1. Candida Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. TB and Drug-resistant TB
5.2.9.1. TB and Drug-resistant TB Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.10. Gastro-intestinal Panel Testing
5.2.10.1. Gastro-intestinal Panel Testing Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.11. Chlamydia
5.2.11.1. Chlamydia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.12. Gonorrhea
5.2.12.1. Gonorrhea Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.13. HPV
5.2.13.1. HPV Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.14. HIV
5.2.14.1. HIV Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.15. Hepatitis C
5.2.15.1. Hepatitis C Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.16. Hepatitis B
5.2.16.1. Hepatitis B Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.17. COVID-19
5.2.17.1. COVID-19 Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.18. Others
5.2.18.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Infectious Disease Market By Technology
6.1. Introduction
6.2. Infectious Disease Revenue (US$ Mn) By Technology
6.2.1. Infectious Disease Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
6.2.2. Immunoassay
6.2.2.1. Immunoassay Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Molecular Diagnostics
6.2.3.1. Molecular Diagnostics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Microbiology
6.2.4.1. Microbiology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Infectious Disease Market By End-use
7.1. Introduction
7.2. Infectious Disease Revenue (US$) By End-use
7.2.1. Infectious Disease Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
7.3. Point of care
7.3.1. Point of care Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Central Laboratories
7.4.1. Central Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.5. Others
7.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Infectious Disease Market By Country
8.1. North America Infectious Disease Overview
8.2. U.S.
8.2.1. U.S. Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.S. Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.2.4. U.S. Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
8.3. Canada
8.3.1. Canada Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Canada Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.3.4. Canada Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Infectious Disease Market By Country
9.1. Europe Infectious Disease Market Overview
9.2. U.K.
9.2.1. U.K. Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.2.3. U.K. Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.2.4. U.K. Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
9.3. Germany
9.3.1. Germany Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3.3. Germany Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.3.4. Germany Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
9.4. France
9.4.1. France Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4.3. France Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.4.4. France Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
9.5. Spain
9.5.1. Spain Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5.3. Spain Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.5.4. Spain Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6.3. Rest of Europe Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.6.4. Rest of Europe Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Infectious Disease Market By Country
10.1. Asia Pacific Infectious Disease Market Overview
10.2. China
10.2.1. China Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.2.2. China Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.2.3. China Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.2.4. China Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.3. Japan
10.3.1. Japan Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.3.2. Japan Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.3.3. Japan Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.3.4. Japan Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.4. India
10.4.1. India Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.4.2. India Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.4.3. India Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.4.4. India Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.5. Australia
10.5.1. Australia Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.5.2. Australia Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.5.3. Australia Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.5.4. Australia Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.6. South Korea
10.6.1. South Korea Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.6.2. South Korea Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.6.3. South Korea Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.6.4. South Korea Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.7.2. Rest of Asia-Pacific Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.7.3. Rest of Asia-Pacific Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
10.7.4. Rest of Asia-Pacific Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Infectious Disease Market By Country
11.1. Latin America Infectious Disease Market Overview
11.2. Brazil
11.2.1. Brazil Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.2.2. Brazil Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.2.3. Brazil Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
11.2.4. Brazil Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
11.3. Mexico
11.3.1. Mexico Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.3.2. Mexico Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.3.3. Mexico Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
11.3.4. Mexico Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.4.2. Rest of Latin America Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.4.3. Rest of Latin America Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
11.4.4. Rest of Latin America Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Infectious Disease Market By Country
12.1. Middle East & Africa Infectious Disease Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.2.2. Saudi Arabia Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.2.3. Saudi Arabia Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
12.2.4. Saudi Arabia Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
12.3. UAE
12.3.1. UAE Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.3.2. UAE Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.3.3. UAE Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
12.3.4. UAE Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Infectious Disease Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.4.2. Rest of Middle East & Africa Infectious Disease Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.4.3. Rest of Middle East & Africa Infectious Disease Market Revenue (US$ Mn) and Forecast By Technology, 2016 – 2027
12.4.4. Rest of Middle East & Africa Infectious Disease Market Revenue (US$ Mn) and Forecast By End-use, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Infectious Disease
13.1. Infectious Disease Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Infectious Disease Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Becton, Dickinson and Company
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Becton, Dickinson and Company 2019 Infectious Disease Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. bioMérieux SA
14.3. Abbott Laboratories
14.4. Quidel Corporation
14.5. OraSure Technologies
14.6. Danaher Corporation
14.7. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2624
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
